Genesystem Statistics
Total Valuation
Genesystem has a market cap or net worth of KRW 66.91 billion. The enterprise value is 54.28 billion.
Market Cap | 66.91B |
Enterprise Value | 54.28B |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
Genesystem has 7.01 million shares outstanding. The number of shares has increased by 1.05% in one year.
Shares Outstanding | 7.01M |
Shares Change (YoY) | +1.05% |
Shares Change (QoQ) | +0.36% |
Owned by Insiders (%) | 18.15% |
Owned by Institutions (%) | 18.43% |
Float | 5.59M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 42.30 |
PB Ratio | 2.31 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -4.82 |
EV / Sales | 34.65 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -7.21 |
Financial Position
The company has a current ratio of 10.40, with a Debt / Equity ratio of 14.22.
Current Ratio | 10.40 |
Quick Ratio | 8.22 |
Debt / Equity | 14.22 |
Debt / EBITDA | n/a |
Debt / FCF | -0.54 |
Interest Coverage | -72.89 |
Financial Efficiency
Return on equity (ROE) is -32.70% and return on invested capital (ROIC) is -14.67%.
Return on Equity (ROE) | -32.70% |
Return on Assets (ROA) | -13.92% |
Return on Capital (ROIC) | -14.67% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.04 |
Inventory Turnover | 0.76 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.32% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -68.32% |
50-Day Moving Average | 9,833.80 |
200-Day Moving Average | 8,237.35 |
Relative Strength Index (RSI) | 45.64 |
Average Volume (20 Days) | 233,028 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Genesystem had revenue of KRW 1.57 billion and -11.27 billion in losses. Loss per share was -1,623.49.
Revenue | 1.57B |
Gross Profit | -904.72M |
Operating Income | -9.05B |
Pretax Income | -9.31B |
Net Income | -11.27B |
EBITDA | -8.64B |
EBIT | -9.05B |
Loss Per Share | -1,623.49 |
Balance Sheet
The company has 16.73 billion in cash and 4.09 billion in debt, giving a net cash position of 12.63 billion or 1,803.22 per share.
Cash & Cash Equivalents | 16.73B |
Total Debt | 4.09B |
Net Cash | 12.63B |
Net Cash Per Share | 1,803.22 |
Equity (Book Value) | 28.78B |
Book Value Per Share | 4,133.79 |
Working Capital | 19.38B |
Cash Flow
In the last 12 months, operating cash flow was -7.36 billion and capital expenditures -166.72 million, giving a free cash flow of -7.53 billion.
Operating Cash Flow | -7.36B |
Capital Expenditures | -166.72M |
Free Cash Flow | -7.53B |
FCF Per Share | -1,074.94 |
Margins
Gross Margin | -57.76% |
Operating Margin | -577.83% |
Pretax Margin | -594.60% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -480.80% |
Dividends & Yields
Genesystem does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.05% |
Shareholder Yield | -1.05% |
Earnings Yield | -17.00% |
FCF Yield | -11.26% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |